FEATURES
The internet has pulled down competition barriers and provided fuel for exponential growth. Todd Wenning explains how to capture the digital revolution in your portfolio.
Finding the cure: gene therapy
Targeted gene therapies are saving lives and restoring eyesight. But they could also hurt profits and increase risks for pharma companies. Megan Boxall reports
SEVEN DAYS
Our take on the biggest business stories of the past week
NEWS
Raven Property battered by currency headwinds
RedT benefits from power security demand
Chaarat Gold plots deal-linked refinancing
Diploma chief exits despite consensus-beating year
News Spotlight – The Social(ist) Network
Economic outlook – The public finance myth, Next week’s economics…
COMMENT
The Editor – Thinking global
Simon Thompson – Bargain Bango, Bowleven drilling disappoints, Sylvania delivers maiden dividend, BATM reveals groundbreaking diagnostic kit
Chris Dillow – Two bull markets, Against lifestyle investing
The Trader – Reviewing January’s outlook
MONEY
Portfolio Clinic – Think carefully about swapping cash for bonds
TIPS
Political fears overblown at John Laing
Buy Old Mutual UK Mid Cap for good value growth
Tip updates
FUNDS
Standard Life Smallers trust delivers strong returns
Funds reflect the risk of their investments
SHARES
Taking Stock – Madame Melgrani’s carbon footprint
Results
South32, an underdog ahead of the pack
Charter Court raises lending guidance
OneSavings boosted by buy-to-let gains
Phoenix raises cash-generation targets
Anglo Pacific rides Rio disposal spree
Premier Oil finance costs rise
Playtech grows in regulated markets
Camellia flags Kenyan pressures
Henry Boot boosted by hungry housebuilders
Kingspan recovers after sluggish start
Computacenter ahead of tech curve
Gym Group converts acquired sites
Bunzl withstands currency headwinds
Macfarlane and the value of specialism
James Fisher expands into renewable energy
Stock screens – Nine British disruptors
Sector Focus – Heatwaves and holidays
Directors dealings
